Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-27

Clinical Trial Update: LY3214996 +/- HCQ in Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of LY3214996 with or without hydroxychloroquine in pancreatic cancer completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)
  • LY3214996

Snippet

Sponsor: Kimberly Perez, MD | Conditions: Pancreatic Cancer, Advanced Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-11-27